CMLD-2

CAS No. 958843-91-9

CMLD-2( —— )

Catalog No. M34849 CAS No. 958843-91-9

CMLD-2 is an inhibitor of HuR-ARE interaction (Ki: 350 nM) that competitively binds HuR protein and disrupts its interaction with adenine element-rich (ARE) mRNA targets.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 149 In Stock
5MG 235 In Stock
10MG 392 In Stock
25MG 622 In Stock
50MG 868 In Stock
100MG 1143 In Stock
500MG 2277 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    CMLD-2
  • Note
    Research use only, not for human use.
  • Brief Description
    CMLD-2 is an inhibitor of HuR-ARE interaction (Ki: 350 nM) that competitively binds HuR protein and disrupts its interaction with adenine element-rich (ARE) mRNA targets.
  • Description
    CMLD-2, an inhibitor of HuR-ARE interaction, competitively binds HuR protein disrupting its interaction with adenine-uridine rich elements (ARE)-containing mRNAs (Ki=350 nM). CMLD-2 induces apoptosis exhibits antitumor activity in different cancer cells as colon, pancreatic, thyroid and lung cancer cell lines. Hu antigen R (HuR) is an RNA binding protein, can regulate target mRNAs stability and translation.
  • In Vitro
    Cell Viability Assay Cell Line:SW1736, 8505C, BCPAP and K1 cells Concentration:1, 5, 10, 25, 35, 50, 75 μM Incubation Time:24, 48, 72 hours Result:Reduced the viability of all the four cell lines when used at 35, 50 and 75?μM concentration and at different time points.Apoptosis AnalysisCell Line:H1299, A549, H1975, HCC827, MRC-9 and CCD16 cells Concentration:20, 30 μM Incubation Time:24, 48 hours Result:Marked activated the caspase-9 and -3 in lung tumor cells.Induce the cleavage of PARP in lung tumor cells.Significantly increased the annexin-V-positive staining in lung tumor cells.Cell Cycle Analysis Cell Line:H1299, A549, MRC-9 and CCD16 cells Concentration:30 μM Incubation Time:24, 48 hours Result:Induced greater G1 phase cell cycle arrest in H1299 and A549 cells than in MRC-9 and CCD16 cells.Western Blot Analysis Cell Line:H1299, A549, H1975, HCC827, CCD16 and MRC-9 cells Concentration:20, 30 μM Incubation Time:24, 48 hours Result:Diminished protein expression of HuR, Bcl-2, Cyclin E and Bcl-XL and increased expression of p27 and BAX in lung tumor cells.
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Apoptosis
  • Target
    Apoptosis
  • Recptor
    Apoptosis | HuR
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    958843-91-9
  • Formula Weight
    513.58
  • Molecular Formula
    C31H31NO6
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 50 mg/mL (97.36 mM; Ultrasonic )
  • SMILES
    COc1ccc(cc1)C(CC(=O)N1CCCC1)c1c(OC)cc(OC)c2c(cc(=O)oc12)-c1ccccc1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Wu X, et, al. Identification and validation of novel small molecule disruptors of HuR-mRNA interaction. ACS Chem Biol. 2015 Jun 19;10(6):1476-84.?
molnova catalog
related products
  • VPC-70063

    VPC-70063 is an inhibitor of c-Myc-MAX. VPC-70063 exhibits Myc-Max transcriptional activity inhibition of 106% with an IC50 of 8.9 μM and Myc-Max/UBE2C downstream pathway inhibition of 94%. VPC-70063 can be used for studies about anticancer.

  • 6-Azauridine

    6-Azauridine (6-Azuridine) is a purine nucleoside analog with a broad spectrum of antitumor activity, targeting malignant tumors of the inert lymphatic system and inducing apoptosis.

  • Bcl-B inhibitor 1

    Bcl-B inhibitor 1 is an antitumor compound that binds to and inactivates pro-apoptotic proteins in the BH3 structural domain.